Patients with HIV are not being screened enough for cancers: Study

According to a latest study finding presented at the Infectious Diseases Society of America 49th Annual Meeting, patients with HIV were less likely to have routine screening for breast, cervical and colon cancer compared with patients without HIV.

The research conducted by a team from St. John Hospital & Medical Center in Detroit was actually a retrospective case-control study to evaluate compliance with American Cancer Society screening guidelines. The study included 78 patients with HIV who were treated by infectious disease specialists and 78 age- and gender-matched patients without HIV who were treated by internal medicine specialists. All patients were seen by their specialists from Jan. 1, 2009, to Dec. 31, 2009. The investigators reviewed charts to see if the ACS screening guidelines were followed.

Results showed that patients with HIV were less likely to be recommended screening and also less likely to have screening performed. When compared with national figure rates for cancer screening, patients treated by internal medicine specialists had a higher rate of screening, whereas patients with HIV had a lower rate of screening. Additionally among the patients with HIV, 56.4% had a primary care provider.

  • For mammograms to detect breast cancer, 91.7% of patients without HIV were ordered to have one, compared with 54.2% of patients with HIV. A mammogram actually was performed in 83.3% of patients without HIV, compared with 45.8% of patients with HIV.
  • For colonoscopy to detect colon cancer, 89.8% of patients without HIV were ordered to have one, compared with 54.2% of patients with HIV. A colonoscopy actually was performed in 67.8% of patients without HIV, compared with 45.8% of patients with HIV.
For Pap smears to detect cervical cancers, 86.7% of patients without HIV were ordered to have one, compared with 60% of patients with HIV. A Pap smear actually was performed in 80% of patients without HIV, compared with 60% of patients with HIV.
Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). Patients with HIV are not being screened enough for cancers: Study. News-Medical. Retrieved on December 24, 2024 from https://www.news-medical.net/news/20111026/Patients-with-HIV-are-not-being-screened-enough-for-cancers-Study.aspx.

  • MLA

    Mandal, Ananya. "Patients with HIV are not being screened enough for cancers: Study". News-Medical. 24 December 2024. <https://www.news-medical.net/news/20111026/Patients-with-HIV-are-not-being-screened-enough-for-cancers-Study.aspx>.

  • Chicago

    Mandal, Ananya. "Patients with HIV are not being screened enough for cancers: Study". News-Medical. https://www.news-medical.net/news/20111026/Patients-with-HIV-are-not-being-screened-enough-for-cancers-Study.aspx. (accessed December 24, 2024).

  • Harvard

    Mandal, Ananya. 2018. Patients with HIV are not being screened enough for cancers: Study. News-Medical, viewed 24 December 2024, https://www.news-medical.net/news/20111026/Patients-with-HIV-are-not-being-screened-enough-for-cancers-Study.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sweden exceeds UNAIDS HIV goals but faces new challenges